Company type
Focused on harnessing the power of chromatin biology and novel drug accumulation approaches to discover and develop a new generation of targeted canceFunding rounds
Series C
( )
Investor | Profile | Country | |
---|---|---|---|
Gilde Investment Management | |||
Phase4 Ventures Ltd | |||
Wellcome Trust |
Investor | Profile | Country | |
---|---|---|---|
Essex Woodlands Health Ventures Inc | |||
ETV Capital SA (European Technology Ventures) | |||
Hercules Technology Growth Capital Inc | Specialised finance company providing debt and equity growth capital to technology-related companies at all stages of development. | ||
University of Cambridge |
Investment activity status
Active investor